Abstract

No abstract available.

Rights

This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.

Cite as

Liew, F., Talwar, S., Cross, A., Willett, B., Scott, S., Logan, N., Siggins, M., Swieboda, D., Sidhu, J., Efstathiou, C., Moore, S., Davis, C., Mohamed, N., Nunag, J., King, C., Thompson, A., Rowland-Jones, S., Docherty, A., Chalmers, J., Ho, L., Horsley, A., Raman, B., Poinasamy, K., Marks, M., Kon, O., Howard, L., Wootton, D., Dunachie, S., Quint, J., Evans, R., Wain, L., Fontanella, S., de Silva, T., Ho, A., Harrison, E., Baillie, J., Semple, M., Brightling, C., Thwaites, R., Turtle, L. & Openshaw, P. 2022, 'SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination', EBioMedicine. https://eprints.gla.ac.uk/286280/

Downloadable citations

Download HTML citationHTML Download BIB citationBIB Download RIS citationRIS
Last updated: 20 August 2024
Was this page helpful?